Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial-Reference-Cited by-同舟云学术

Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial

Published:2020-02-24 Issue:3 Volume:28 Page:529-536
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Wadden Thomas A.¹^ORCID,Tronieri Jena Shaw¹,Sugimoto Danny²,Lund Michael Taulo³,Auerbach Pernille³,Jensen Camilla³,Rubino Domenica⁴

Affiliation:

1. Department of Psychiatry Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

2. Cedar Crosse Research Center Chicago Illinois USA

3. Novo Nordisk A/S Søborg Denmark

4. Washington Center for Weight Management and Research Arlington Virginia USA

Funder

Novo Nordisk

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.22726

Reference30 articles.

1. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

2. Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children

3. World Health Organization.Obesity and overweight.http://www.who.int/mediacentre/factsheets/fs311/en/. Published February 16 2018. Accessed August 8 2019.

4. National Institute for Health and Care Excellence.Obesity: identification assessment and management. Clinical guideline [CG189].https://www.nice.org.uk/guidance/cg189. Published November 2014. Accessed August 8 2019.

5. Intensive Lifestyle Intervention for Obesity: Principles, Practices, and Results

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approved and Emerging Hormone-Based Anti-Obesity Medications: A Review Article;Indian Journal of Endocrinology and Metabolism;2024-09-04

2. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Journal of Preventive Cardiology;2024-08-30

3. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Heart Journal;2024-08-30

4. Medications for Obesity;JAMA;2024-08-20

5. Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity;Drugs;2024-07-06